[Neuroinflammation in the Brain of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome].
Nakatomi, Yasuhito, Kuratsune, Hirohiko, Watanabe, Yasuyoshi · Brain and nerve = Shinkei kenkyu no shinpo · 2018 · DOI
Quick Summary
Researchers used a special imaging scan called PET to look at the brains of people with ME/CFS and found signs of inflammation (immune system activation) throughout several brain regions. This inflammation was connected to how severe patients' symptoms were, including problems with thinking and memory, as well as widespread pain. This discovery suggests that ME/CFS involves measurable changes in the brain that could eventually lead to better ways to diagnose and treat the condition.
Why It Matters
This research provides objective neurobiological evidence for ME/CFS—demonstrating that the condition involves measurable physical changes in the brain rather than being purely psychological. For patients, these findings validate that their symptoms have a biological basis and could accelerate development of diagnostic tests and targeted treatments based on reducing neuroinflammation.
Observed Findings
Widespread neuroinflammation was detected in multiple brain regions of ME/CFS patients using PET imaging.
The extent of neuroinflammation correlated with severity of neuropsychological symptoms.
Cognitive impairment and chronic widespread pain showed associations with detected brain inflammation.
Inflammatory markers were present across diverse brain areas rather than being localized to a single region.
Inferred Conclusions
Neuroinflammation is a measurable biological feature of ME/CFS that could support development of objective diagnostic criteria.
The relationship between brain inflammation severity and symptom severity suggests neuroinflammation as a potential therapeutic target.
These findings support the biological rather than purely psychological nature of ME/CFS pathophysiology.
Remaining Questions
Does neuroinflammation precede symptom onset, develop after symptom initiation, or both?
Are specific inflammatory markers more important than others for understanding ME/CFS pathology?
Could anti-inflammatory treatments reduce both neuroinflammation and clinical symptoms in ME/CFS patients?
What This Study Does Not Prove
This study does not prove that neuroinflammation is the sole cause of ME/CFS or establish whether inflammation is primary or secondary to other disease processes. It shows correlation between inflammation and symptom severity but does not determine causation or whether treating inflammation would resolve symptoms. The study also does not establish whether these inflammatory changes persist long-term or how they develop.